Hide Board Information

Show Board Information

Sanuwave Health Inc SNWV

Board Mod: SHEEPWOLF

Asst Mods:

Last Post: 06/07/2022 8:50:53 AM

Board Marks: 2

Posts Today: 0

Board Views Today: 78

Sanuwave Health Inc (OTCMRKTS: SNWV) Stock Message Board

1. SNWV Company Profile

    

2. SNWV Time & Sales

    

3. SNWV Recent News

    

4. SNWV Filings

    

5. SNWV Financials

    

6. SNWV Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

289	$SNWV: NEW DD PACK!! SEE THIS EXCITING US FDA	SHEEPWOLF	08/24/2019 11:38:36 PM
292	$SNWV GROSSLY UNDERVALUED RELATIVE TO ITS PEERS	SHEEPWOLF	08/28/2019 9:18:38 AM
293	$SNWV: ZACK'S PRICE TARGET JUST OUT	SHEEPWOLF	09/04/2019 8:54:57 AM
3	SNWV Financials 07/15/2014 18:56:25 SANUWAVE	Emylers	07/15/2014 7:56:23 PM
2	SNWV 0.66 Stock Charts $SNWV 1 Month Chart	chartguy89	03/09/2014 10:54:18 PM
1	SNWV Stock Charts Last: -0.0298 Saturday, March	chartguy89	03/01/2014 5:44:55 PM

Newer

Recent Articles

• American Rebel Responds to Misleading Media About S-1 Filing
• CamScanner Enhances Document Scanning with New Capture Feature
• Movano Inc. Stock Surges Significantly on Listing Extension News
• Strathcona Resources' Strategic Move to Enhance Shareholding
• Friends of Science Society Raises Concerns Over Net Zero Demands
• Secure Your Rights: Advocating for Replimune Group Investors
• RxSight Securities Class Action: What Investors Need to Know
• Pollo AI Unveils Game-Changing AI Tool for Creators
• Global Leaders Gather for China's Significant 80th V-Day Event
• Gmail's Spam Filtering Under Fire: Is Political Bias at Play?
• Secure Your Rights: Luminar Technologies Investors Alert
• Investors of Sable Offshore Corp. Urged to Act Promptly
• Investors of Lockheed Martin Corporation Must Act Quickly for Class Action
• PharmaResearch Partners with VIVACY to Boost 'Rejuran' in Europe
• Bitcoin Holds Steady While Altcoins Face Disappointing Trends
• PharmaResearch Forms New Alliance for Rejuran Across Europe
• PharmaResearch Partners with VIVACY for Expanded European Reach
• Solar Alliance Energy Inc. Prepares For Market Re-entry After Trading Pause
• SF Intra-city Reports Surge in Revenue and Growth for 2025
• TMC Financing Welcomes Omar Salah as New President and CEO
• Concerns Rise Over Salmonella Outbreak from Eggs in the U.S.
• Top Five Stocks Captivating Investors This Trading Day
• SF Intra-city's Exceptional Performance Fuels Dynamic Growth
• Apex Institute Disrupts Job Training with AI-Driven Bootcamp
• TransUnion Faces Major Data Breach Investigation Amidst Chaos
• Experience Edo Culture Through Unique Tokyo Tours and Cruises
• Soma Gold Corp Posts Strong Financial Results for Q2 2025
• E&R Engineering to Showcase Cutting-Edge Tech at SEMICON 2025
• Exciting Launch of the Mini Labubu Pendant on AliExpress
• Exciting Developments at Freedom Plaza with Local Support
• Netflix Stock Surges as Power Inflow Signals Uptrend
• Exploring E&R's Cutting-Edge Technologies at SEMICON Taiwan
• Mesoblast's Milestones: FDA Approval and Strategic Growth
• Highlights of Mesoblast's Record Year: FDA Approval and Growth
• Replimune Group Inc. Class Action Update for Shareholders
• Faruqi & Faruqi Investigates Replimune Group for Shareholders
• Frontier Lithium Releases Financial Milestones and Updates
• Expansion in Water Sector: Scruggs and NTS Join Forces
• Gamehaus Holdings Inc. Launches Strategic Share Buyback Plan
• Bogotá's Strategic Mission to Enhance Investment with Japan
• Exciting Developments at Picard Medical with $17 Million IPO
• Eagle Pharmaceuticals Welcomes Abhinav Jain to Its Board
• Stetson University Celebrated for Distinction in Education
• Sable Offshore Investors Rally: Legal Actions Begin
• Transform Your Investment Strategy with US Foods Holdings Today
• Investors Alert: LifeMD Inc Faces Legal Investigation Risks
• Everest Medicines Reports Strong Interim Growth in 2025
• Simply Solventless Sees Exceptional Growth with $13 Million in Revenue
• Everest Medicines Reports Strong Financial Growth for H1 2025
• Exploring Adobe's Stock Growth Track Record Over Two Decades